Softgels are becoming an increasingly popular dosage form to help you overcome low solubility challenges, increase new revenue streams, maximize your market potential, and more. Working with the right vendor is key. Learn more about the value we bring to pharmaceutical and consumer healthcare companies, the patient benefits associated with softgels, and the diverse technologies Thermo Fisher Scientific has to offer. Click here.
By Anil Kane, Ph.D.,Thermo Fisher Scientific
With few potential blockbuster drugs in the pharma pipeline right now, drug companies are increasingly looking at other options to meet the needs of patients and increase revenue in the oral solid dosage arena.
By Joe Hirano,GE Healthcare Life Sciences
Biologics developers and manufacturers demand an accurate and reliable assay for host cell protein (HCP) quantitation. Let’s take a close look at why analytical scientists turn to the ELISA, and how it fits into process development.
A client was exploring the possibility of re-purposing an internal collection of antifungal CYP51A1 inhibitors for targeting cancers. Learn how a CYP51A1 inhibitor screening assay and screening of client compounds moved the project forward in a cost-effective manner.